Riskpilot← Back to searchSign inGet full accessJM Pharmacy AB
ABActiveOrg 5568200637Gyllenstiernsgatan 12Activities of employment placement agencies · NACE 7810Est. 20101 employees
Revenue 2025
SEK 0
EBITDA margin
—
-125% vs 2024
Equity ratio
66.2%
Financial strength
Net profit 2025
SEK -17K
-107% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -70K | -125% |
| Net profit | SEK -17K | -107% |
| Total assets | SEK 806K | -29% |
| Equity | SEK 534K | -3% |
| Employees | 1 | — |
Legal name
JM Pharmacy AB
Org number
5568200637
Legal form
Aktiebolag
NACE code
7810 · Activities of employment placement agencies
Founded
29 september 2010
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva tillverkning och handel med farmaceutiska produkter och läkemedel samt kosmetika och hygienartiklar, samt utföra konsultuppdrag inom chefsrekrytering, styrelserekrytering, karriärcoachning, ledarcoachning och HR-management
Address
Gyllenstiernsgatan 12
Email
jarlmolin@jmpharmacy.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 955 | 934 | 488 | 664 | 0 |
| Staff expenses | — | −591 | −485 | −281 | −5 |
| EBITDA | 252 | 186 | −88 | 282 | −70 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 252 | 186 | −88 | 282 | −70 |
| Net financials | — | — | −1 | 1 | 0 |
| Profit before tax | 252 | 211 | 12 | 335 | −17 |
| Tax | −54 | −47 | −8 | −75 | — |
| Net profit | 198 | 164 | 3 | 260 | −17 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 713 | 1 601 | 1 040 | 1 143 | 806 |
| Equity | 1 174 | 838 | 591 | 551 | 534 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 184 | 434 | 220 | 415 | 148 |
| Total debt | 184 | 434 | 220 | 415 | 148 |
EBITDA margin
-7035900.0%
This company
15.8%
Market median
-44531113% vs market
20212025
Equity ratio
66.2%
This company
38.2%
Market median
+73% vs market
20212025
Return on equity
-3.2%
This company
18.4%
Market median
-117% vs market
20212025
Net profit margin
-1711200.0%
This company
8.1%
Market median
-21126026% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.51×
This company
0.62×
Market median
+18% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JK Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of JM Pharmacy AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jarl Kristian Molin | Chief Executive Officer | 0 companies |
| Lars Sigvard Jerker Karlsson | Deputy Board Member | 0 companies |